ID 1633 - Phospholidips (Phosphatidyl choline, Phosphatidyl ethanolamine, Phosphatidyl inositol, Lysophosphatidyl cholin)

PL:
EN: Phospholidips (Phosphatidyl choline, Phosphatidyl ethanolamine, Phosphatidyl inositol, Lysophosphatidyl cholin)
Pdf:

1.11. Choline (ID 712, 1633)

The food that is the subject of the health claims is “phospholipids (phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl inositol, lysophosphatidyl cholin)”.
Phospholipids are a major component of all cell membranes. Most phospholipids contain a diglyceride, a phosphate group, and a simple organic molecule such as choline.
From the conditions of use, the Panel assumes that the food, which is the subject of the health claim, is phosphatidylcholine, and that the food constituent responsible for the claimed effect is choline. Choline is measurable in foods by established methods.
The Panel considers that the food constituent, choline, which is the subject of the health claim, is sufficiently characterised (EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2011b)

2.14. Choline and maintenance of normal liver function (ID 712, 1633)

The claimed effect is “liver health”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings and the clarifications provided by Member States, the Panel assumes that the claimed effects refer to the maintenance of normal liver function.
A claim on choline and maintenance of normal liver function has already been assessed with a favourable outcome (EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2011b)

Warunki i możliwe ograniczenia stosowania oświadczenia

Min 1 g per day